T1D Research: New Scientific Statement & Future Directions
endocrine Society Issues Scientific Statement on type 1 Diabetes, Outlining Key Research Opportunities
Table of Contents
The Endocrine Society has released a thorough Scientific Statement focused on type 1 diabetes (T1D), identifying critical research gaps and proposing new avenues for investigation. This statement aims to guide scientists, physicians, and funding agencies in accelerating advancements towards improved understanding, treatment, and prevention of this autoimmune disease.
the Growing Burden of Type 1 Diabetes
Type 1 diabetes is a chronic autoimmune condition where the body’s immune system mistakenly attacks and destroys insulin-producing beta cells in the pancreas. As of 2024, approximately 9 million people worldwide are living with T1D, according to the International Diabetes Federation, with prevalence varying significantly across different countries. Despite ongoing research, the precise causes and contributing factors remain largely unknown, highlighting the urgent need for further investigation.
New Insights and Research Priorities
The Endocrine Society’s statement builds upon the widely recognized Eisenbarth model of T1D progression, which outlines the stages leading to the disease.Researchers propose the addition of a “Stage 0” to this model, acknowledging that crucial events likely occur before the currently understood stages 1, 2, and 3.This addition emphasizes the importance of identifying and studying these early, currently unknown, disease processes.
The statement identifies several key areas for focused research:
Genetics: unraveling the genetic predispositions to T1D.
Heterogeneity: Recognizing the diverse ways T1D manifests in different individuals.
Pancreatic pathology: Deepening understanding of the immune attack on the pancreas.
β Cell Function and Mass: Assessing how beta cell function declines and how to preserve or restore beta cell mass.
Immunologic Biomarkers: Identifying biomarkers in the blood that can predict disease advancement.
Exocrine Pancreas Changes: Investigating potential alterations in the exocrine pancreas related to T1D.
Population-Based screening: Implementing widespread screening programs to identify individuals at risk.
“The data highlights the need for population-based screening for type 1 diabetes and more research into the causes of the disease,” stated Dr. Alvin C.Powers,of Vanderbilt University Medical Center and a member of the writing group. “We hope addressing these research gaps and incorporating more widespread screening efforts will help identify those at risk sooner and improve treatment and long-term health outcomes for people living with type 1 diabetes.”
Leveraging Emerging Technologies for Breakthroughs
The statement emphasizes the potential of incorporating emerging technological and analytical tools into T1D research. These advancements promise to provide a more nuanced understanding of the disease’s pathogenesis - the underlying mechanisms of how it develops. Researchers believe this new understanding is crucial for developing more effective therapies and preventative strategies.
Collaborative Effort and Publication Details
The Scientific Statement was a collaborative effort led by Dr. alvin C.Powers and included contributions from:
Aaron Michels, University of Colorado School of Medicine
Todd Brusko, University of Florida
Carmella Evans-molina, Indiana University School of Medicine and the Roudebush VA Medical Center
Dirk Homann, University of Miami
Sarah Richardson, University of Exeter Medical School
The statement, titled “Challenges and Opportunities for Understanding the Pathogenesis of type 1 Diabetes: An Endocrine Society Scientific Statement,” was published online in The Journal of Clinical Endocrinology & Metabolism (doi.org/10.1210/clinem/dgaf267).
Source: Michels, A. W., et al. (2025) Challenges and Opportunities for Understanding the Pathogenesis of Type 1 Diabetes: An Endocrine Society Scientific Statement. The journal of Clinical Endocrinology & Metabolism. doi.org/10.1210/clinem/dgaf267.